RECRUITING

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Official Title

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort

Quick Facts

Study Start:2017-09-15
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03408353

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 80 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Willingness to participate in the study and ability to provide informed consent
  2. * Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
  3. * Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.
  1. * Current or recent (within the prior 6 months) history of breast feeding
  2. * Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
  3. * Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Contacts and Locations

Study Contact

Jessica Leung
CONTACT
713-745-4555
jwleung@mdanderson.org

Principal Investigator

Jessica W Leung
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Jessica W Leung, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-09-15
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2017-09-15
Study Completion Date2025-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Carcinoma